FDA Inspection 1032279 — Kyowa Kirin Pharmaceutical Development, Inc.

Kyowa Kirin Pharmaceutical Development, Inc. — FEI 3005634747

The FDA completed an inspection of Kyowa Kirin Pharmaceutical Development, Inc. on Nov 29, 2017 in Princeton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 29, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Princeton, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
745321 CFR 312.56(b)Investigator non-compliance

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.